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Abstract
Objective: The objective of this study was to evaluate the cost-effectiveness of a Multidisciplinary Integrated Care (MIC)
model compared to Usual Care (UC) in Dutch residential homes.
Methods: The economic evaluation was conducted from a societal perspective alongside a 6 month, clustered, randomized
controlled trial involving 10 Dutch residential homes. Outcome measures included a quality of care weighted sum score,
functional health (COOP WONCA) and Quality Adjusted Life-Years (QALY). Missing cost and effect data were imputed using
multiple imputation. Bootstrapping was used to analyze differences in costs and cost-effectiveness.
Results: The quality of care sum score in MIC was significantly higher than in UC. The other primary outcomes showed no
significant differences between the MIC and UC. The costs of providing MIC were approximately J225 per patient. Total
costs were J2,061 in the MIC group and J1,656 for the UC group (mean difference J405, 95% 213; 826). The probability
that the MIC was cost-effective in comparison with UC was 0.95 or more for ceiling ratios larger than J129 regarding patient
related quality of care. Cost-effectiveness planes showed that the MIC model was not cost-effective compared to UC for the
other outcomes.
Interpretation: Clinical effect differences between the groups were small but quality of care was significantly improved in
the MIC group. Short term costs for MIC were higher. Future studies should focus on longer term economic and clinical
effects.
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Introduction
In nearly every country around the world, the proportion of
people aged over 60 years is growing faster than any other age
group [1]. Long-term care costs are largely affected by this
increase because long-term care expenses tend to increase
markedly with old age [2]. As the aging population intensifies its
demand and uptake of healthcare services, the contextual
landscape is one of a decreasing labor market, higher demands
for quality of care voiced by baby boomers, and uncertainty of
incomes of older people [3,4].
Approximately 10% of all Dutch elderly over the age of 75 live
in elderly housing [5,6]. Of this population, over 70% require
professional assistance with activities of daily living, nursing care
and housekeeping [5,6]. There are approximately 100 residents
per residential home [3]. When senior citizens enter into a
residential home, they keep their general practitioner if possible.
There is a trend to keep the elderly in their own homes for as long
as possible to maximize their level of independence as well as it can
be less expensive from a governmental perspective [7,8]. As a
consequence, the residential home population resembles nursing
home populations more and more [9,10,11,12]. Residential homes
were not designed to address these populations and primary care
physicians are challenged by these complex patients [9,13,14].
Most care organizations want to innovate and improve their
quality of care but lack expertise or financial resources [9,13,15].
The Multidisciplinary Integrated Care (MIC) model is inspired by
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the chronic care model [16,17] and is a multidisciplinary approach
that may improve quality of care [18]. The objective of this study
was to determine the cost-effectiveness of the MIC model
compared to usual care (UC) in a sample of 10 residential homes
in the Netherlands. In an earlier paper, it was found that the MIC
model resulted in significantly higher quality of care [18].
Methods
Design and setting
A clustered, randomized controlled trial with 6 month follow-up
was conducted in 10 Dutch residential homes [9]. Residential
homes were randomized to either the intervention or control
group resulting in each arm of the trial including 5 residential
homes. A detailed description of the design was published
elsewhere [9,18]. The protocol for this trial and supporting
CONSORT checklist are available as supporting information; see
Protocol S1 and Checklist S1. Randomization was carried out on
at the level of care facilities after matching for percentage of
cognitively impaired residents, based on the assumption that a
high percentage of cognitive residents would affect care-related
needs and services. In the matching procedure, the two facilities
with the highest percentage of cognitively impaired residents were
matched, and so on. Randomization was carried out using the first
column from Pocock’s random numbers table. The average
number of residents in each facility was 46, and staff included
nurse assistants and a house manager.
Ethics statement
The ethical committee of the VU Medical Center approved the
study.
Resident selection
Patients were recruited from December 2006 until December
2007. All residents within the 10 residential homes were invited to
participate in the clinical trial. A patient was excluded from the
study if he/she was viewed by the staff or primary care physician
as too terminally ill to complete the study [9]. All residents were
listed at a general practitioner who was responsible for their
medical care. Participating residents in each facility were visited by
trained, blinded interviewers at baseline and at six months to assess
other outcomes.
If the resident was unable to understand the questions, a close
family member was identified by staff and asked to act as a proxy.
The interview consisted of a computerized assessment of
functional health, activities of daily living, depression, cognition,
satisfaction with care, and use of medications. All participants or
their representative signed informed consent.
The UC model
A residential home is a retirement home for seniors who can no
longer live independently [19]. Residential homes typically offer
general care such as; domestic help, leisure activities and meals for
all occupants or a large portion of the occupants [19]. Ad hoc
nursing care for individual occupants is also possible. No new
interventions were introduced into this arm of the study. Care
providers were instructed to continue the care to the patients that
they would normally provide.
The MIC
The intervention of the MIC model consists of three steps [9].
Firstly, a quarterly in-home systematic and computerized multi-
dimensional assessment of all residents by trained nurse-assistants
systematically reviewed the functional health status and care needs
using the InterRAI-LTCF which is a comprehensive, standardized
instrument for evaluating the needs, strengths, and preferences of
those in chronic care and nursing home institutional settings [20].
The InterRAI-LTCF assessment form incorporates domains such
as; function, mental and physical health, social support, medica-
tion and service use [20]. The problem areas identified become the
foundation for the individual care plan [20]. Secondly, the
outcomes of the assessment were discussed in a multidisciplinary
meeting in the homes with the primary care physician, nursing
home physician, nurse, psychotherapist and other involved
disciplines. Lastly, a multidisciplinary consultation was offered to
the frailest residents with complex health care problems which
were identified by the level of expected resource utilization [9,21].
Clinical outcomes measures
The primary outcome was the sum score of the 32 risk-adjusted
quality-of-care indicators [18]. The quality-of care indicators were
based on observations recorded in the Long-term Care Facility
assessment form [22]. The itemized observations needed to
calculate these indicators were rated by independent trained
interviewers. Inter-rater reliability of the quality-of-care indicators
between interviewers and nurse-assistants in the intervention
facilities was satisfactory (mean intra-cluster correlation single
measure 0.74). The sum score of the quality-of-care indicators was
determined by the number of indicators that were present per
resident divided by the number of applicable indicators per
resident. An example of a quality indicator is the presence of a
feeding tube. Lower sum scores indicate higher quality of care.
Functional health, an important aspect of quality of life, was
measured by COOP WONCA charts [23]. The COOPWonca
chart consists of six dimensions: physical fitness, feelings, daily
activities, social activities, change in health and overall health.
These dimensions combined form a total COOPWonca score.
Higher scores are indicative of better functional health.
The 12- Item Short Form health survey (SF12) was used to
measure general quality of life. Based on The SF12 data, Quality
Adjusted Life Years (QALY) were calculated using utility scores
estimated by the SF6D tariff [24]. Transitions between health
states were linearly interpolated.
Cost outcome measures
Cost data were collected at baseline and six months from a
societal perspective. Health care utilization data was collected by
patient or proxy interview and medical records at baseline and at
six months [9]. Table 1 lists the cost categories and prices used in
the economic evaluation. All prices were adjusted for the year
2007 using consumer price index figures [25]. Costs of medica-
tions were valued using prices from the Royal Dutch Society for
Pharmacy [26]. We calculated informal care hours, primary and
secondary care consumption, medication use and costs associated
with the intervention. Normally productivity costs are included but
this is an admitted population therefore the costs were not
relevant.
A cost price for MIC was calculated using a top down approach.
Total costs included: organizational costs, training costs, InterRAI
costs and multidisciplinary meeting costs (see Table 1). Costs were
calculated on an annual basis and then proportioned for the six
month trial. Total costs of the intervention were divided by the
total number of residents living in the intervention residential
homes. Multidisciplinary meetings are part of usual care by law.
However, in daily practice, not all homes hold these meetings on a
regular basis. We also calculated costs for the meetings held in the
usual care home. In a sensitivity analysis, only the license costs of
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the InterRAI and the InterRAI subscription costs per patient were
included.
Statistical analysis
Data was analyzed according to the intention to treat principle.
However, patients who did not provide baseline data or died
during the study were excluded from the analyses. The multiple
imputation function in SPSS-18 was used to predict missing values
for cost and effect data. This function created five imputed data
sets that were pooled together using Rubin’s rules [27]. Individual
cost components were imputed at a patient level instead of overall
total cost per patient to minimize unnecessary deletion of
information.
As patient-level cost data have a highly skewed distribution,
bootstrapping was performed with 5000 replications to estimate
Approximate Bootstrap Confidence (ABC) intervals around cost
differences [28,29]. Incremental cost-effectiveness ratios (ICERs)
were calculated by dividing the difference in total costs between
MIC and UC by the difference in clinical effects. Non-parametric
bootstrapping was also used to estimate the uncertainty surround-
ing the ICERs (5000 replications). The bootstrapped cost-effect
pairs were plotted on a cost-effectiveness plane (CE plane) [30]
and used to estimate cost-effectiveness acceptability curves (CEA
curves). CEA curves illustrate the probability that the intervention
is cost-effective in comparison with the control treatment for a
range of ceiling ratios. The ceiling ratio is defined as the societal
willingness to pay in order to gain one unit of effect [31].
Three sensitivity analyses were performed. One included only
the complete cases and the second one included only the licensing
and subscription costs of the interRAI as described above. In the
third sensitivity analysis, people who provided no baseline data or
died were included in the analysis. Missing cost and effect data
were imputed based multiple imputation of available baseline
clinical and cost data.
Results
From December 2006 until December 2007, a total of 462
residents were requested to participate in the trial. There were 340
patients randomized. At baseline, 340 people were included (201
intervention patients and 139 control patients). There were no
significant differences in patient characteristics between the two
groups at baseline (Table 2). There were no baseline data for 5
patients (2 intervention and 3 control patients). A total of 34 people
died (16 (12%) control and 18 (9%) intervention patients) before the
six month follow up. Thus, all main analyses were based on imputed
data including 181 intervention and 120 control residents. Com-
plete clinical outcome data was available for 137 patients (68%) in
the intervention group and 70 (50%) patients in the control group.
Selectively missing data was found as the participants that dropped
out were approximately two years older (95%CI 0.42; 3.66) and had
better activities of daily living score as measured by the Groningen
Activity Restriction Scale (GARS) compared to completers (mean
difference 23.4, 95% CI 26.7; 20.1).
Clinical effectiveness
Quality of care was significantly higher in the intervention
group than the control group (mean difference 26.5, 95% CI
Table 1. Costs – in the economic evaluation using consumer
price index figures (in Euros) [25].
Cost category J (2007)
Primary care costs
General practitioner
-Visit to GP (per visit) 21.36
-Visit from GP (per visit) 42.73
-Contact by telephone 10.66
Physical therapy
-Physiotherapy (per visit) 22.40
-Ergotherapy (per visit) 53.03
Psychosocial therapy
-Psychologist (per visit) 81.02
-Psychiatrist (per visit) 80.38
-Social psychiatric nurse (per visit) 80.38
Secondary care costs
Medical specialist
-Geriatrician (per visit) 177.69
-Other specialists (per visit) 59.23
Admission to hospital
-Day care (per day)* 242.15
-Overnight stay (per day)* 353.35
Informal care (per hour) 8.78
MIC costs J
-Organizational costs 2,510
-Training of staff 6,824
-Performing interRAI 1,999
-Meeting costs 1,780
Total costs 13,113
Cost per patient 225
*Price including costs medical specialist, nurses, medication, housing costs,
medical equipment.
doi:10.1371/journal.pone.0037444.t001
Table 2. Mean (SD) baseline characteristics of intervention
and control groups.
Intervention
(N=201)
Control
(N=136)
Mean age 86 (6.2) 85 (8.0)
Female (%) 76 74
Education
-Primary school or less 112 (56) 79 (58)
-Lower Technical vocational training 45 (22) 26 (19)
-Average and higher vocational training 34 (17) 30 (22)
-Missing 10 (5) 1 (1)
Marital status, n (%)
-Married 42 (21) 27 (20)
-Widowed 130 (65) 93 (68)
-Single 19 (9) 15 (11)
-Missing 10 (5) 1 (1)
Physical Component Scale of the SF 12 34 (8.3) 33 (7.2)
Mental Component Scale of the SF 12 53 (9.3) 51(11.1)
Baseline utility SF-6D 0.64 (0.1) 0.64 (0.1)
COOP WONCA 18 (3.7) 18 (4.1)
doi:10.1371/journal.pone.0037444.t002
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29.5; 23.5). However, there was no statistically significant
difference in effect for either of the other outcome measures
(Table 3). Mean QALY scores for both groups were approximately
0.3 (n = 181 for intervention group and n= 120 for the usual care
group) indicating that there was no difference in quality of life over
the six month study.
Costs
Costs of the intervention amounted to J225. There was a trend
that total costs were higher in the intervention group compared to
UC by J404 (95% CI 213; 826, Table 4). Direct healthcare costs
were the largest contributor to total costs in both groups. The
highest cost driver within direct healthcare costs for both groups
was secondary care costs such as hospital admission (Table 4).
Cost-effectiveness analysis
Quality Indicators. The sum score of quality of care resulted
in a negative ICER of 62, indicating that for every one point
improvement on the sum score, the MIC model costs J62
compared to UC. Figures 1 and 2 show the CE plane and CEA
curve. The majority of the cost- effectiveness pairs (97%) were in
the northeast quadrant suggesting that the intervention is more
significantly more effective and more costly than UC. The CEA
curve showed that with a 0.95 probability that the MIC was cost-
effective compared to UC the societal willingness to pay should be
approximately J129 or more per point of improvement on the
quality of care scale.
Coop WONCA. The ICER for the COOP WONCA was
2,056 meaning that 1 point improvement in COOP WONCA
score costs J2,056 for MIC versus UC. The majority (97%) of the
cost-effect pairs fell in the Northern quadrants of the CEA plane
indicating that total costs in the MIC are higher compared to UC
while there is a statistically non-significant difference in effects.
The CEA curve showed that the maximum probability that the
MIC was cost-effective compared to UC was 0.6. However, to
reach this probability the societal willingness to pay should be
approximately J5,000 per one point improvement.
QALY. The ICER for QALY scores was 2248,308 indicating
the MIC had higher costs and negative effects compared to UC.
Figures 3 and 4 show the CE plane and CEA curve. Most (63%)
bootstrapped cost effect pairs were contained in the Northwest
quadrant meaning that the MIC was less effective and more costly
than UC. The CEA curve presented in Figure 4 shows that the
maximum probability that MIC is cost-effective in comparison
with usual care was 0.14 regardless of the willingness to pay.
Sensitivity analysis
The results of the clinical outcomes in the complete case analysis
were consistent with those of the imputation analysis. Total costs
were higher in the intervention group than in the control group
but not statistically significantly which is consistent with the
imputed analysis. Although the conclusion for the cost effective-
ness analysis was the same for both the imputed and complete case
analysis the numbers varied (data not shown).
The second sensitivity analysis including only licensing and
subscription costs for interRAI showed that total costs were not
significantly different between the intervention and the control
group. Conclusions on the cost-effectiveness of MIC in compar-
ison with usual care did not change in this analysis.
The third sensitivity analysis included people who died between
baseline and sixmonths follow-up in addition to the participantswho
missed the baseline measurement. We found that there was no
significant difference in costs between the intervention and the
control.
Table 3. Differences in clinical outcomes at 6 months.
Outcome measure
MIC
(n = 181)
UC
(n= 120)
Difference
(95% CI)
Primary outcomes
Quality Indicator
Score*
11.12 (1.1) 17.63 (1.0) 26.5 (29.5; 23.5)
COOP WONCA 0.85 (0.3) 0.65 (0.6) 0.2 (21.1; 1.5)
QALY 0.31 (0.003) 0.32 (0.004) 0.00 (20.01; 0.01)
*Lower scores indicate better quality of care.
doi:10.1371/journal.pone.0037444.t003
Table 4. Mean (SD) and cost differences J (95% CI) during
follow-up at 6 months.
Cost category
Intervention
(n =181)
Control
(n =120) Difference
Direct costs
-Direct healthcare costs 1,469 (158) 1,351 (161) 117 (2292;
529)
Primary care costs 299 (37) 389 (74) 288 (2277;
48)
Secondary care costs 745 (143) 533 (135) 215 (2146;
579)
Medications 419 (40) 429 (31) 28 (284; 114)
-Informal care costs 367 (47) 282 (32) 77 (210; 204)
-Implementation costs* 225 23 202
Total costs 2,061 (163) 1,656 (163) 405 (213; 826)
*Implementation costs consist of the MIC costs in the intervention group and of
the costs of the multi-disciplinary meetings in the control group.
doi:10.1371/journal.pone.0037444.t004
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Figure 1. Cost-effectiveness plane for the difference in quality
of care sum score at 6 months (in Euros).
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Discussion
Summary
An economic evaluation was performed to determine whether
the MIC was cost-effective compared to UC. General scales of
functional health did not significantly differ between the groups at
six month although quality of care was significantly higher in the
MIC group. There was a trend that total costs were higher in the
MIC than UC. For functional health and QALYs we concluded
that the MIC was not cost-effective compared to UC. Whether
MIC is considered cost-effective in comparison with UC for
quality of care depends on the amount of money decision makers
are willing to additionally spend on care for this group of elderly
nursing home residents. Conclusions were similar in the complete
case analysis.
Explanation of the findings
This raises the question why was quality of care higher in the
intervention homes compared to the control homes? It is possible
the quality indicators in the control homes did not improve to the
same extent as in the intervention homes because intervention
participants were receiving increased attention from the residential
home staff as well as increased referrals to secondary care. The
increase in secondary care may have induced the need for the
informal caregiver to attend and help transport patients to the
secondary care appointments which may explain the increased
informal care costs. If there was unmet care, then the use of the
interRAI and the multidisciplinary meetings addressed this gap in
care. However, a trade-off needs to be made whether the
additional effects are worth the additional costs.
Existing literature comparison
Previous studies suggest interRAI has positive effects on health
outcomes in nursing facilities as well as in residential homes
[32,33]. However, there were criticisms on the study designs and
the conclusions drawn indicating a need for better designed trials
[34]. A four month trial from New Zealand estimated health care
services utilized and the cost of implementing the minimum data
set home care assessment compared with UC [35]. They found
that the interRAI was significantly more costly in prescribed and
delivered services compared to UC but the author believed that
the cost differences may be due to a genuine need of services for
this population [35]. We think that our trial is an important
addition to the knowledge base on the effect of the interRAI in
clinical care.
Limitations
The six month follow-up may not have been enough to capture
all potential costs and effects. The duration of the trial was
relatively short because of a high risk for drop out owing to the
extreme vulnerability of residents and because the umbrella care
organization intended to implement the care model in the control
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Figure 2. Cost- effectiveness acceptability curve for the quality
of care sum score at 6 months (in Euros).
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scores at 6 months (in Euros).
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facilities as well. Patients in a residential home have a heteroge-
neous mix of chronic conditions that naturally erode health over
time which makes it difficult to know if an intervention of this sort
would be able to override the downward trend of health states
associated with chronic conditions in such a short time span. The
primary outcome variables may not have been sensitive enough to
pick up differences within such a limited time interval. Another
limitation was the considerable amount of missing data. In this
study, non-completers tended to be older and had better activities
of daily living scores. As the intervention really targeted only the
frailest it could be that they did not feel like they were benefitting
enough from the study intervention. In situations where there are
missing costs, multiple imputation is recommended which was also
performed in this study.
Conclusion
This study showed benefit on quality of care, against a modest
cost increase. Longer term follow up of costs and effects is needed
to further substantiate the findings. Future research should
consider the reasons why it did not translate over to the other
clinical outcome variables. Its pragmatic study design resembles
clinical practice to a high degree which increases the relevance of
the study results.
Future research should consider the reasons why these patients
in the Multidisciplinary Integrated Care group had higher quality
of care indicators and why it did not translate over to the other
clinical outcome variables. Moreover, ways to decrease MIC
implementation costs could be beneficial for future cost-effective-
ness analyses.
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